Mucoadhesive and ROS-responsive polymeric vesicles for anti-angiogenic therapy in corneal neovascularization.
Corneal neovascularization (CNV) is a major cause of visual impairment worldwide and results from disruption of the cornea's angiogenic privilege by excessive angiogenic signaling and oxidative stress. Current clinical management relies on corticosteroids, nonsteroidal anti-inflammatory drugs, or anti-VEGF injections,...